Literature DB >> 7528363

Nephrotoxicity of immunosuppressive drugs.

W M Bennett1, E A Burdmann, T F Andoh, D C Houghton, J Lindsley, L W Elzinga.   

Abstract

Acute and chronic nephrotoxicity frequently limits the therapeutic benefits of immunosuppressive therapy for transplant and autoimmune indications. The clinical aspects, pathophysiology, and relevant pharmacology of current and future immunosuppressive drugs are reviewed in this paper. Insights gained from experimental models of chronic nephrotoxicity associated with tubulointerstitial fibrosis are presented.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7528363

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


  6 in total

Review 1.  Immunosuppressant-induced nephropathy: pathophysiology, incidence and management.

Authors:  A J Olyaei; A M de Mattos; W M Bennett
Journal:  Drug Saf       Date:  1999-12       Impact factor: 5.606

2.  Annexin A1 protein attenuates cyclosporine-induced renal hemodynamics changes and macrophage infiltration in rats.

Authors:  Leandro Pires Araujo; Renata Ramos Truzzi; Gloria Elisa Florido Mendes; Marcus Alexandre Mendes Luz; Emmanuel A Burdmann; Sonia Maria Oliani
Journal:  Inflamm Res       Date:  2011-11-19       Impact factor: 4.575

3.  Use of uric acid-lowering agents limits experimental cyclosporine nephropathy.

Authors:  Fernanda Cristina Mazali; Richard J Johnson; Marilda Mazzali
Journal:  Nephron Exp Nephrol       Date:  2011-11-25

4.  The results of 1009 kidney transplantations performed in Hungary.

Authors:  F Perner; J Járay; F Alföldy; M Hídvégi; K Darvas; D Görög; A Tóth; T Gondos; E Toronyi; G Petrányi
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

Review 5.  The role of medications and their management in acute kidney injury.

Authors:  Bradford L McDaniel; Michael L Bentley
Journal:  Integr Pharm Res Pract       Date:  2015-05-18

Review 6.  Gentamicin nephrotoxicity in animals: Current knowledge and future perspectives.

Authors:  Pavle Randjelovic; Slavimir Veljkovic; Nenad Stojiljkovic; Dušan Sokolovic; Ivan Ilic
Journal:  EXCLI J       Date:  2017-03-24       Impact factor: 4.068
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.